BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20336779)

  • 1. Computer-assisted Papanicolaou imaging : another valuable tool in the challenge of Papanicolaou test screening for glandular neoplasia.
    Austin RM
    Cancer Cytopathol; 2010 Apr; 118(2):65-7. PubMed ID: 20336779
    [No Abstract]   [Full Text] [Related]  

  • 2. Whole-Slide Imaging of Pap Cellblock Preparations Is a Potentially Valid Screening Method.
    Tawfik O; Davis M; Dillon S; Tawfik L; Diaz FJ; Amin K; Fan F
    Acta Cytol; 2015; 59(2):187-200. PubMed ID: 25967603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we improve the detection of glandular cervical lesions: the role and limitations of the Pap smear diagnosis atypical glandular cells (AGC).
    Duska LR
    Gynecol Oncol; 2009 Sep; 114(3):381-2. PubMed ID: 19647129
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant.
    Uyar DS; Eltabbakh GH; Mount SL
    Gynecol Oncol; 2003 May; 89(2):227-32. PubMed ID: 12713984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BD focalpoint slide profiler performance with atypical glandular cells on SurePath Papanicolaou smears.
    Chute DJ; Lim H; Kong CS
    Cancer Cytopathol; 2010 Apr; 118(2):68-74. PubMed ID: 20209621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fortuitous detection of endocervical adenocarcinoma in situ: a report of 2 cases.
    Gurney EP; Blank SV
    J Reprod Med; 2009 Jul; 54(7):451-3. PubMed ID: 19691263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of atypical glandular cells in cervical Papanicolaou smears.
    Lojindarat S; Luengmettakul J; Puangsa-Art S
    J Med Assoc Thai; 2012 Aug; 95(8):975-82. PubMed ID: 23061299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observer variation in cytologic grading for cervical dysplasia of Papanicolaou smears with the PAPNET testing system.
    Doornewaard H; van der Schouw YT; van der Graaf Y; Bos AB; van den Tweel JG
    Cancer; 1999 Aug; 87(4):178-83. PubMed ID: 10455204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid-based cytology and conventional cervical smears: a comparison study in an Asian screening population.
    Cheung AN; Szeto EF; Leung BS; Khoo US; Ng AW
    Cancer; 2003 Dec; 99(6):331-5. PubMed ID: 14681939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Only a small fraction of high-grade cervical lesions are discovered after an interpretation of atypical squamous cells of undetermined significance when using imager-assisted, liquid-based papanicolaou tests and the Bethesda 2001 system.
    Khan KA; Smith DA; Thrall MJ
    Arch Pathol Lab Med; 2013 Jul; 137(7):936-41. PubMed ID: 22994456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the science: cervical cancer screening in transition.
    Dinkelspiel H; Kinney W
    Gynecol Oncol; 2014 Jun; 133(3):389-93. PubMed ID: 24878390
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinicopathological Characteristics of Atypical Glandular Cells Determined by Cervical Cytology in Japan: Survey of Gynecologic Oncology Data from the Obstetrical Gynecological Society of Kinki District, Japan.
    Toyoda S; Kawaguchi R; Kobayashi H
    Acta Cytol; 2019; 63(5):361-370. PubMed ID: 31048578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathological outcome of ThinPrep Pap tests diagnosed as glandular cell abnormalities alone versus combined glandular and squamous abnormalities.
    Harbhajanka A; Chahar S; Michael CW
    Diagn Cytopathol; 2019 Feb; 47(2):88-93. PubMed ID: 30451396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of adjunctive high-risk human papillomavirus DNA testing in women with Papanicolaou test findings of atypical glandular cells.
    Zhao C; Florea A; Austin RM
    Arch Pathol Lab Med; 2010 Jan; 134(1):103-8. PubMed ID: 20073612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical glandular cells of undetermined significance on cervical smears. A study with cytohistologic correlation.
    Burja IT; Thompson SK; Sawyer WL; Shurbaji MS
    Acta Cytol; 1999; 43(3):351-6. PubMed ID: 10349361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunistic screening for cervical cancer in a tertiary hospital in Karnataka, India.
    Kulkarni PR; Rani H; Vimalambike MG; Ravishankar S
    Asian Pac J Cancer Prev; 2013; 14(9):5101-5. PubMed ID: 24175783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of cytological features of glandular lesions of the cervix on conventional smear preparations-a comprehensive study from a tertiary care hospital.
    Mantri S; Ravikumar G; Crasta J
    Diagn Cytopathol; 2021 Mar; 49(3):388-394. PubMed ID: 33211413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results.
    Lonky NM; Sadeghi M; Tsadik GW; Petitti D
    Am J Obstet Gynecol; 1999 Sep; 181(3):560-6. PubMed ID: 10486464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses.
    Kinney WK; Manos MM; Hurley LB; Ransley JE
    Obstet Gynecol; 1998 Jun; 91(6):973-6. PubMed ID: 9611007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical Pap screening among Israeli women, 2005-2010.
    Bassal R; Schejter E; Bachar R; Shapira H; Sandbank J; Supino Rosin L; Schvimer M; Cohen D; Keinan-Boker L
    Arch Gynecol Obstet; 2014 Mar; 289(3):615-22. PubMed ID: 24085583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.